Global Circulating Tumor Cells Market Growth (Status and Outlook) 2021-2026

  • receipt Report ID : 240281
  • calendar_today Published On: Apr, 2021
  • file_copy Pages: 134
  • list Pharmaceuticals and Healthcare

According to this latest study, the 2021 growth of Circulating Tumor Cells will have significant change from previous year. By the most conservative estimates of global Circulating Tumor Cells market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 1287.5 million in 2020. Over the next five years the Circulating Tumor Cells market will register a 21.2% CAGR in terms of revenue, the global market size will reach US$ 2774.7 million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Circulating Tumor Cells market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.

CTC Enrichment

CTC Detection

CTC Analysis

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.

Breast Cancer

Prostate Cancer

Colorectal Cancer

Lung Cancer

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

Menarini-Silicon Biosystems

Qiagen (Adnagen)

Advanced Cell Diagnostics

ApoCell

Epic Sciences

Greiner Bio-one GmbH

Cynvenio

SurExamBio-Tech

Fluxion Biosciences

Ikonisys

Hangzhou Watson Biotech

Biocept

CytoTrack

Guangzhou Wondfo Biotech

Celsee

Clearbridge Biomedics

ANGLE plc

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Circulating Tumor Cells Market Size 2016-2026

2.1.2 Circulating Tumor Cells Market Size CAGR by Region 2020 VS 2021 VS 2026

2.2 Circulating Tumor Cells Segment by Type

2.2.1 CTC Enrichment

2.2.2 CTC Enrichment

2.2.3 CTC Analysis

2.3 Circulating Tumor Cells Market Size by Type

2.3.1 Global Circulating Tumor Cells Market Size CAGR by Type

2.3.2 Global Circulating Tumor Cells Market Size Market Share by Type (2016-2021)

2.4 Circulating Tumor Cells Segment by Application

2.4.1 Breast Cancer

2.4.2 Prostate Cancer

2.4.3 Colorectal Cancer

2.4.4 Lung Cancer

2.4.5 Others

2.5 Circulating Tumor Cells Market Size by Application

2.5.1 Global Circulating Tumor Cells Market Size CAGR by Application

2.5.2 Global Circulating Tumor Cells Market Size Market Share by Application (2016-2021)

3 Circulating Tumor Cells Market Size by Players

3.1 Circulating Tumor Cells Market Size Market Share by Players

3.1.1 Global Circulating Tumor Cells Revenue by Players (2019-2021E)

3.1.2 Global Circulating Tumor Cells Revenue Market Share by Players (2019-2021E)

3.2 Global Circulating Tumor Cells Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Circulating Tumor Cells by Regions

4.1 Circulating Tumor Cells Market Size by Regions (2016-2021)

4.2 Americas Circulating Tumor Cells Market Size Growth (2016-2021)

4.3 APAC Circulating Tumor Cells Market Size Growth (2016-2021)

4.4 Europe Circulating Tumor Cells Market Size Growth (2016-2021)

4.5 Middle East & Africa Circulating Tumor Cells Market Size Growth (2016-2021)

5 Americas

5.1 Americas Circulating Tumor Cells Market Size by Country (2016-2021)

5.2 Americas Circulating Tumor Cells Market Size by Type (2016-2021)

5.3 Americas Circulating Tumor Cells Market Size by Application (2016-2021)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Circulating Tumor Cells Market Size by Region (2016-2021)

6.2 APAC Circulating Tumor Cells Market Size by Type (2016-2021)

6.3 APAC Circulating Tumor Cells Market Size by Application (2016-2021)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Circulating Tumor Cells by Country (2016-2021)

7.2 Europe Circulating Tumor Cells Market Size by Type (2016-2021)

7.3 Europe Circulating Tumor Cells Market Size by Application (2016-2021)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Circulating Tumor Cells by Region (2016-2021)

8.2 Middle East & Africa Circulating Tumor Cells Market Size by Type (2016-2021)

8.3 Middle East & Africa Circulating Tumor Cells Market Size by Application (2016-2021)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Global Circulating Tumor Cells Market Forecast

10.1 Global Circulating Tumor Cells Forecast by Regions (2021-2026)

10.1.1 Global Circulating Tumor Cells Forecast by Regions (2021-2026)

10.1.2 Americas Circulating Tumor Cells Forecast

10.1.3 APAC Circulating Tumor Cells Forecast

10.1.4 Europe Circulating Tumor Cells Forecast

10.1.5 Middle East & Africa Circulating Tumor Cells Forecast

10.2 Americas Circulating Tumor Cells Forecast by Countries (2021-2026)

10.2.1 United States Circulating Tumor Cells Market Forecast

10.2.2 Canada Circulating Tumor Cells Market Forecast

10.2.3 Mexico Circulating Tumor Cells Market Forecast

10.2.4 Brazil Circulating Tumor Cells Market Forecast

10.3 APAC Circulating Tumor Cells Forecast by Region (2021-2026)

10.3.1 China Circulating Tumor Cells Market Forecast

10.3.2 Japan Circulating Tumor Cells Market Forecast

10.3.3 Korea Circulating Tumor Cells Market Forecast

10.3.4 Southeast Asia Circulating Tumor Cells Market Forecast

10.3.5 India Circulating Tumor Cells Market Forecast

10.3.6 Australia Circulating Tumor Cells Market Forecast

10.4 Europe Circulating Tumor Cells Forecast by Country (2021-2026)

10.4.1 Germany Circulating Tumor Cells Market Forecast

10.4.2 France Circulating Tumor Cells Market Forecast

10.4.3 UK Circulating Tumor Cells Market Forecast

10.4.4 Italy Circulating Tumor Cells Market Forecast

10.4.5 Russia Circulating Tumor Cells Market Forecast

10.5 Middle East & Africa Circulating Tumor Cells Forecast by Region (2021-2026)

10.5.1 Egypt Circulating Tumor Cells Market Forecast

10.5.2 South Africa Circulating Tumor Cells Market Forecast

10.5.3 Israel Circulating Tumor Cells Market Forecast

10.5.4 Turkey Circulating Tumor Cells Market Forecast

10.5.5 GCC Countries Circulating Tumor Cells Market Forecast

10.6 Global Circulating Tumor Cells Forecast by Type (2021-2026)

10.8 Global Circulating Tumor Cells Forecast by Application (2021-2026)

11 Key Players Analysis

11.1 Menarini-Silicon Biosystems

11.1.1 Menarini-Silicon Biosystems Company Information

11.1.2 Menarini-Silicon Biosystems Circulating Tumor Cells Product Offered

11.1.3 Menarini-Silicon Biosystems Circulating Tumor Cells Revenue, Gross Margin and Market Share (2019-2021)

11.1.4 Menarini-Silicon Biosystems Main Business Overview

11.1.5 Menarini-Silicon Biosystems Latest Developments

11.2 Qiagen (Adnagen)

11.2.1 Qiagen (Adnagen) Company Information

11.2.2 Qiagen (Adnagen) Circulating Tumor Cells Product Offered

11.2.3 Qiagen (Adnagen) Circulating Tumor Cells Revenue, Gross Margin and Market Share (2019-2021)

11.2.4 Qiagen (Adnagen) Main Business Overview

11.2.5 Qiagen (Adnagen) Latest Developments

11.3 Advanced Cell Diagnostics

11.3.1 Advanced Cell Diagnostics Company Information

11.3.2 Advanced Cell Diagnostics Circulating Tumor Cells Product Offered

11.3.3 Advanced Cell Diagnostics Circulating Tumor Cells Revenue, Gross Margin and Market Share (2019-2021)

11.3.4 Advanced Cell Diagnostics Main Business Overview

11.3.5 Advanced Cell Diagnostics Latest Developments

11.4 ApoCell

11.4.1 ApoCell Company Information

11.4.2 ApoCell Circulating Tumor Cells Product Offered

11.4.3 ApoCell Circulating Tumor Cells Revenue, Gross Margin and Market Share (2019-2021)

11.4.4 ApoCell Main Business Overview

11.4.5 ApoCell Latest Developments

11.5 Epic Sciences

11.5.1 Epic Sciences Company Information

11.5.2 Epic Sciences Circulating Tumor Cells Product Offered

11.5.3 Epic Sciences Circulating Tumor Cells Revenue, Gross Margin and Market Share (2019-2021)

11.5.4 Epic Sciences Main Business Overview

11.5.5 Epic Sciences Latest Developments

11.6 Greiner Bio-one GmbH

11.6.1 Greiner Bio-one GmbH Company Information

11.6.2 Greiner Bio-one GmbH Circulating Tumor Cells Product Offered

11.6.3 Greiner Bio-one GmbH Circulating Tumor Cells Revenue, Gross Margin and Market Share (2019-2021)

11.6.4 Greiner Bio-one GmbH Main Business Overview

11.6.5 Greiner Bio-one GmbH Latest Developments

11.7 Cynvenio

11.7.1 Cynvenio Company Information

11.7.2 Cynvenio Circulating Tumor Cells Product Offered

11.7.3 Cynvenio Circulating Tumor Cells Revenue, Gross Margin and Market Share (2019-2021)

11.7.4 Cynvenio Main Business Overview

11.7.5 Cynvenio Latest Developments

11.8 SurExamBio-Tech

11.8.1 SurExamBio-Tech Company Information

11.8.2 SurExamBio-Tech Circulating Tumor Cells Product Offered

11.8.3 SurExamBio-Tech Circulating Tumor Cells Revenue, Gross Margin and Market Share (2019-2021)

11.8.4 SurExamBio-Tech Main Business Overview

11.8.5 SurExamBio-Tech Latest Developments

11.9 Fluxion Biosciences

11.9.1 Fluxion Biosciences Company Information

11.9.2 Fluxion Biosciences Circulating Tumor Cells Product Offered

11.9.3 Fluxion Biosciences Circulating Tumor Cells Revenue, Gross Margin and Market Share (2019-2021)

11.9.4 Fluxion Biosciences Main Business Overview

11.9.5 Fluxion Biosciences Latest Developments

11.10 Ikonisys

11.10.1 Ikonisys Company Information

11.10.2 Ikonisys Circulating Tumor Cells Product Offered

11.10.3 Ikonisys Circulating Tumor Cells Revenue, Gross Margin and Market Share (2019-2021)

11.10.4 Ikonisys Main Business Overview

11.10.5 Ikonisys Latest Developments

11. Hangzhou Watson Biotech

11.11.1 Hangzhou Watson Biotech Company Information

11.11.2 Hangzhou Watson Biotech Circulating Tumor Cells Product Offered

11.11.3 Hangzhou Watson Biotech Circulating Tumor Cells Revenue, Gross Margin and Market Share (2019-2021)

11.11.4 Hangzhou Watson Biotech Main Business Overview

11.11.5 Hangzhou Watson Biotech Latest Developments

11.12 Biocept

11.12.1 Biocept Company Information

11.12.2 Biocept Circulating Tumor Cells Product Offered

11.12.3 Biocept Circulating Tumor Cells Revenue, Gross Margin and Market Share (2019-2021)

11.12.4 Biocept Main Business Overview

11.12.5 Biocept Latest Developments

11.13 CytoTrack

11.13.1 CytoTrack Company Information

11.13.2 CytoTrack Circulating Tumor Cells Product Offered

11.13.3 CytoTrack Circulating Tumor Cells Revenue, Gross Margin and Market Share (2019-2021)

11.13.4 CytoTrack Main Business Overview

11.13.5 CytoTrack Latest Developments

11.14 Guangzhou Wondfo Biotech

11.14.1 Guangzhou Wondfo Biotech Company Information

11.14.2 Guangzhou Wondfo Biotech Circulating Tumor Cells Product Offered

11.14.3 Guangzhou Wondfo Biotech Circulating Tumor Cells Revenue, Gross Margin and Market Share (2019-2021)

11.14.4 Guangzhou Wondfo Biotech Main Business Overview

11.14.5 Guangzhou Wondfo Biotech Latest Developments

11.15 Celsee

11.15.1 Celsee Company Information

11.15.2 Celsee Circulating Tumor Cells Product Offered

11.15.3 Celsee Circulating Tumor Cells Revenue, Gross Margin and Market Share (2019-2021)

11.15.4 Celsee Main Business Overview

11.15.5 Celsee Latest Developments

11.16 Clearbridge Biomedics

11.16.1 Clearbridge Biomedics Company Information

11.16.2 Clearbridge Biomedics Circulating Tumor Cells Product Offered

11.16.3 Clearbridge Biomedics Circulating Tumor Cells Revenue, Gross Margin and Market Share (2019-2021)

11.16.4 Clearbridge Biomedics Main Business Overview

11.16.5 Clearbridge Biomedics Latest Developments

11.17 ANGLE plc

11.17.1 ANGLE plc Company Information

11.17.2 ANGLE plc Circulating Tumor Cells Product Offered

11.17.3 ANGLE plc Circulating Tumor Cells Revenue, Gross Margin and Market Share (2019-2021)

11.17.4 ANGLE plc Main Business Overview

11.17.5 ANGLE plc Latest Developments

12 Research Findings and Conclusion

List of Tables

Table 1. Circulating Tumor Cells Market Size CAGR by Region (2020-2026) & ($ Millions)

Table 2. Major Players of CTC Enrichment

Table 3. Major Players of CTC Detection

Table 4. Major Players of CTC Analysis

Table 5. Circulating Tumor Cells Market Size CAGR by Type (2020-2026) & ($ Millions)

Table 6. Global Circulating Tumor Cells Market Size by Type (2016-2021) & ($ Millions)

Table 7. Global Circulating Tumor Cells Market Size Market Share by Type (2016-2021)

Table 8. Circulating Tumor Cells Market Size CAGR by Application (2016-2021) & ($ Millions)

Table 9. Global Circulating Tumor Cells Market Size by Application (2016-2021) & ($ Millions)

Table 10. Global Circulating Tumor Cells Market Size Market Share by Application (2016-2021)

Table 11. Global Circulating Tumor Cells Revenue by Players (2019-2021E) & ($ Millions)

Table 12. Global Circulating Tumor Cells Revenue Market Share by Players (2019-2021E)

Table 13. Circulating Tumor Cells Key Players Head office and Products Offered

Table 14. Circulating Tumor Cells Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E)

Table 15. New Products and Potential Entrants

Table 16. Mergers & Acquisitions, Expansion

Table 17. Global Circulating Tumor Cells Market Size by Regions 2016-2021 & ($ Millions)

Table 18. Global Circulating Tumor Cells Market Size Market Share by Regions 2016-2021

Table 19. Americas Circulating Tumor Cells Market Size by Country (2016-2021) & ($ Millions)

Table 20. Americas Circulating Tumor Cells Market Size Market Share by Country (2016-2021)

Table 21. Americas Circulating Tumor Cells Market Size by Type (2016-2021) & ($ Millions)

Table 22. Americas Circulating Tumor Cells Market Size Market Share by Type (2016-2021)

Table 23. Americas Circulating Tumor Cells Market Size by Application (2016-2021) & ($ Millions)

Table 24. Americas Circulating Tumor Cells Market Size Market Share by Application (2016-2021)

Table 25. APAC Circulating Tumor Cells Market Size by Region (2016-2021) & ($ Millions)

Table 26. APAC Circulating Tumor Cells Market Size Market Share by Region (2016-2021)

Table 27. APAC Circulating Tumor Cells Market Size by Type (2016-2021) & ($ Millions)

Table 28. APAC Circulating Tumor Cells Market Size Market Share by Type (2016-2021)

Table 29. APAC Circulating Tumor Cells Market Size by Application (2016-2021) & ($ Millions)

Table 30. APAC Circulating Tumor Cells Market Size Market Share by Application (2016-2021)

Table 31. Europe Circulating Tumor Cells Market Size by Country (2016-2021) & ($ Millions)

Table 32. Europe Circulating Tumor Cells Market Size Market Share by Country (2016-2021)

Table 33. Europe Circulating Tumor Cells Market Size by Type (2016-2021) & ($ Millions)

Table 34. Europe Circulating Tumor Cells Market Size Market Share by Type (2016-2021)

Table 35. Europe Circulating Tumor Cells Market Size by Application (2016-2021) & ($ Millions)

Table 36. Europe Circulating Tumor Cells Market Size Market Share by Application (2016-2021)

Table 37. Middle East & Africa Circulating Tumor Cells Market Size by Region (2016-2021) & ($ Millions)

Table 38. Middle East & Africa Circulating Tumor Cells Market Size Market Share by Region (2016-2021)

Table 39. Middle East & Africa Circulating Tumor Cells Market Size by Type (2016-2021) & ($ Millions)

Table 40. Middle East & Africa Circulating Tumor Cells Market Size Market Share by Type (2016-2021)

Table 41. Middle East & Africa Circulating Tumor Cells Market Size by Application (2016-2021) & ($ Millions)

Table 42. Middle East & Africa Circulating Tumor Cells Market Size Market Share by Application (2016-2021)

Table 43. Key and Potential Regions of Circulating Tumor Cells

Table 44. Key Application and Potential Industries of Circulating Tumor Cells

Table 45. Key Challenges of Circulating Tumor Cells

Table 46. Key Trends of Circulating Tumor Cells

Table 47. Global Circulating Tumor Cells Market Size Forecast by Regions (2021-2026) & ($ Millions)

Table 48. Global Circulating Tumor Cells Market Size Market Share Forecast by Regions (2021-2026)

Table 49. Global Circulating Tumor Cells Market Size Forecast by Type (2021-2026) & ($ Millions)

Table 50. Global Circulating Tumor Cells Market Size Market Share Forecast by Type (2021-2026)

Table 51. Global Circulating Tumor Cells Market Size Forecast by Application (2021-2026) & ($ Millions)

Table 52. Global Circulating Tumor Cells Market Size Market Share Forecast by Application (2021-2026)

Table 53. Menarini-Silicon Biosystems Details, Company Type, Circulating Tumor Cells Area Served and Its Competitors

Table 54. Menarini-Silicon Biosystems Circulating Tumor Cells Product Offered

Table 55. Menarini-Silicon Biosystems Circulating Tumor Cells Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 56. Menarini-Silicon Biosystems Main Business

Table 57. Menarini-Silicon Biosystems Latest Developments

Table 58. Qiagen (Adnagen) Details, Company Type, Circulating Tumor Cells Area Served and Its Competitors

Table 59. Qiagen (Adnagen) Circulating Tumor Cells Product Offered

Table 60. Qiagen (Adnagen) Main Business

Table 61. Qiagen (Adnagen) Circulating Tumor Cells Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 62. Qiagen (Adnagen) Latest Developments

Table 63. Advanced Cell Diagnostics Details, Company Type, Circulating Tumor Cells Area Served and Its Competitors

Table 64. Advanced Cell Diagnostics Circulating Tumor Cells Product Offered

Table 65. Advanced Cell Diagnostics Main Business

Table 66. Advanced Cell Diagnostics Circulating Tumor Cells Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 67. Advanced Cell Diagnostics Latest Developments

Table 68. ApoCell Details, Company Type, Circulating Tumor Cells Area Served and Its Competitors

Table 69. ApoCell Circulating Tumor Cells Product Offered

Table 70. ApoCell Main Business

Table 71. ApoCell Circulating Tumor Cells Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 72. ApoCell Latest Developments

Table 73. Epic Sciences Details, Company Type, Circulating Tumor Cells Area Served and Its Competitors

Table 74. Epic Sciences Circulating Tumor Cells Product Offered

Table 75. Epic Sciences Main Business

Table 76. Epic Sciences Circulating Tumor Cells Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 77. Epic Sciences Latest Developments

Table 78. Greiner Bio-one GmbH Details, Company Type, Circulating Tumor Cells Area Served and Its Competitors

Table 79. Greiner Bio-one GmbH Circulating Tumor Cells Product Offered

Table 80. Greiner Bio-one GmbH Main Business

Table 81. Greiner Bio-one GmbH Circulating Tumor Cells Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 82. Greiner Bio-one GmbH Latest Developments

Table 83. Cynvenio Details, Company Type, Circulating Tumor Cells Area Served and Its Competitors

Table 84. Cynvenio Circulating Tumor Cells Product Offered

Table 85. Cynvenio Main Business

Table 86. Cynvenio Circulating Tumor Cells Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 87. Cynvenio Latest Developments

Table 88. SurExamBio-Tech Details, Company Type, Circulating Tumor Cells Area Served and Its Competitors

Table 89. SurExamBio-Tech Circulating Tumor Cells Product Offered

Table 90. SurExamBio-Tech Main Business

Table 91. SurExamBio-Tech Circulating Tumor Cells Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 92. SurExamBio-Tech Latest Developments

Table 93. Fluxion Biosciences Details, Company Type, Circulating Tumor Cells Area Served and Its Competitors

Table 94. Fluxion Biosciences Circulating Tumor Cells Product Offered

Table 95. Fluxion Biosciences Main Business

Table 96. Fluxion Biosciences Circulating Tumor Cells Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 97. Fluxion Biosciences Latest Developments

Table 98. Ikonisys Details, Company Type, Circulating Tumor Cells Area Served and Its Competitors

Table 99. Ikonisys Circulating Tumor Cells Product Offered

Table 100. Ikonisys Main Business

Table 101. Ikonisys Circulating Tumor Cells Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 102. Ikonisys Latest Developments

Table 103. Hangzhou Watson Biotech Details, Company Type, Circulating Tumor Cells Area Served and Its Competitors

Table 104. Hangzhou Watson Biotech Circulating Tumor Cells Product Offered

Table 105. Hangzhou Watson Biotech Circulating Tumor Cells Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 106. Hangzhou Watson Biotech Main Business

Table 107. Hangzhou Watson Biotech Latest Developments

Table 108. Biocept Details, Company Type, Circulating Tumor Cells Area Served and Its Competitors

Table 109. Biocept Circulating Tumor Cells Product Offered

Table 110. Biocept Main Business

Table 111. Biocept Circulating Tumor Cells Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 112. Biocept Latest Developments

Table 113. CytoTrack Details, Company Type, Circulating Tumor Cells Area Served and Its Competitors

Table 114. CytoTrack Circulating Tumor Cells Product Offered

Table 115. CytoTrack Main Business

Table 116. CytoTrack Circulating Tumor Cells Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 117. CytoTrack Latest Developments

Table 118. Guangzhou Wondfo Biotech Details, Company Type, Circulating Tumor Cells Area Served and Its Competitors

Table 119. Guangzhou Wondfo Biotech Circulating Tumor Cells Product Offered

Table 120. Guangzhou Wondfo Biotech Main Business

Table 121. Guangzhou Wondfo Biotech Circulating Tumor Cells Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 122. Guangzhou Wondfo Biotech Latest Developments

Table 123. Celsee Details, Company Type, Circulating Tumor Cells Area Served and Its Competitors

Table 124. Celsee Circulating Tumor Cells Product Offered

Table 125. Celsee Main Business

Table 126. Celsee Circulating Tumor Cells Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 127. Celsee Latest Developments

Table 128. Clearbridge Biomedics Details, Company Type, Circulating Tumor Cells Area Served and Its Competitors

Table 129. Clearbridge Biomedics Circulating Tumor Cells Product Offered

Table 130. Clearbridge Biomedics Main Business

Table 131. Clearbridge Biomedics Circulating Tumor Cells Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 132. Clearbridge Biomedics Latest Developments

Table 133. ANGLE plc Details, Company Type, Circulating Tumor Cells Area Served and Its Competitors

Table 134. ANGLE plc Circulating Tumor Cells Product Offered

Table 135. ANGLE plc Main Business

Table 136. ANGLE plc Circulating Tumor Cells Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 137. ANGLE plc Latest Developments

List of Figures

Figure 1. Circulating Tumor Cells Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Circulating Tumor Cells Market Size Growth Rate 2016-2026 ($ Millions)

Figure 6. Global Circulating Tumor Cells Market Size Market Share by Type in 2020

Figure 7. Circulating Tumor Cells in Breast Cancer

Figure 8. Global Circulating Tumor Cells Market: Breast Cancer (2016-2021) & ($ Millions)

Figure 9. Circulating Tumor Cells in Prostate Cancer

Figure 10. Global Circulating Tumor Cells Market: Prostate Cancer (2016-2021) & ($ Millions)

Figure 11. Circulating Tumor Cells in Colorectal Cancer

Figure 12. Global Circulating Tumor Cells Market: Colorectal Cancer (2016-2021) & ($ Millions)

Figure 13. Circulating Tumor Cells in Lung Cancer

Figure 14. Global Circulating Tumor Cells Market: Lung Cancer (2016-2021) & ($ Millions)

Figure 15. Circulating Tumor Cells in Others

Figure 16. Global Circulating Tumor Cells Market: Others (2016-2021) & ($ Millions)

Figure 17. Global Circulating Tumor Cells Market Size Market Share by Application in 2020

Figure 18. Global Circulating Tumor Cells Revenue Market Share by Player in 2020

Figure 19. Global Circulating Tumor Cells Market Size Market Share by Regions (2016-2021)

Figure 20. Americas Circulating Tumor Cells Market Size 2016-2021 ($ Millions)

Figure 21. APAC Circulating Tumor Cells Market Size 2016-2021 ($ Millions)

Figure 22. Europe Circulating Tumor Cells Market Size 2016-2021 ($ Millions)

Figure 23. Middle East & Africa Circulating Tumor Cells Market Size 2016-2021 ($ Millions)

Figure 24. Americas Circulating Tumor Cells Market Size Market Share by Country in 2020

Figure 25. Americas Circulating Tumor Cells Market Size Market Share by Type in 2020

Figure 26. Americas Circulating Tumor Cells Market Size Market Share by Application in 2020

Figure 27. United States Circulating Tumor Cells Market Size Growth 2016-2021 ($ Millions)

Figure 28. Canada Circulating Tumor Cells Market Size Growth 2016-2021 ($ Millions)

Figure 29. Mexico Circulating Tumor Cells Market Size Growth 2016-2021 ($ Millions)

Figure 30. APAC Circulating Tumor Cells Market Size Market Share by Regions in 2020

Figure 31. APAC Circulating Tumor Cells Market Size Market Share by Type in 2020

Figure 32. APAC Circulating Tumor Cells Market Size Market Share by Application in 2020

Figure 33. China Circulating Tumor Cells Market Size Growth 2016-2021 ($ Millions)

Figure 34. Japan Circulating Tumor Cells Market Size Growth 2016-2021 ($ Millions)

Figure 35. Korea Circulating Tumor Cells Market Size Growth 2016-2021 ($ Millions)

Figure 36. Southeast Asia Circulating Tumor Cells Market Size Growth 2016-2021 ($ Millions)

Figure 37. India Circulating Tumor Cells Market Size Growth 2016-2021 ($ Millions)

Figure 38. Australia Circulating Tumor Cells Market Size Growth 2016-2021 ($ Millions)

Figure 39. Europe Circulating Tumor Cells Market Size Market Share by Country in 2020

Figure 40. Europe Circulating Tumor Cells Market Size Market Share by Type in 2020

Figure 41. Europe Circulating Tumor Cells Market Size Market Share by Application in 2020

Figure 42. Germany Circulating Tumor Cells Market Size Growth 2016-2021 ($ Millions)

Figure 43. France Circulating Tumor Cells Market Size Growth 2016-2021 ($ Millions)

Figure 44. UK Circulating Tumor Cells Market Size Growth 2016-2021 ($ Millions)

Figure 45. Italy Circulating Tumor Cells Market Size Growth 2016-2021 ($ Millions)

Figure 46. Russia Circulating Tumor Cells Market Size Growth 2016-2021 ($ Millions)

Figure 47. Middle East & Africa Circulating Tumor Cells Market Size Market Share by Region in 2020

Figure 48. Middle East & Africa Circulating Tumor Cells Market Size Market Share by Type in 2020

Figure 49. Middle East & Africa Circulating Tumor Cells Market Size Market Share by Application in 2020

Figure 50. Egypt Circulating Tumor Cells Market Size Growth 2016-2021 ($ Millions)

Figure 51. South Africa Circulating Tumor Cells Market Size Growth 2016-2021 ($ Millions)

Figure 52. Israel Circulating Tumor Cells Market Size Growth 2016-2021 ($ Millions)

Figure 53. Turkey Circulating Tumor Cells Market Size Growth 2016-2021 ($ Millions)

Figure 54. GCC Country Circulating Tumor Cells Market Size Growth 2016-2021 ($ Millions)

Figure 55. Americas Circulating Tumor Cells Market Size 2021-2026 ($ Millions)

Figure 56. APAC Circulating Tumor Cells Market Size 2021-2026 ($ Millions)

Figure 57. Europe Circulating Tumor Cells Market Size 2021-2026 ($ Millions)

Figure 58. Middle East & Africa Circulating Tumor Cells Market Size 2021-2026 ($ Millions)

Figure 59. United States Circulating Tumor Cells Market Size 2021-2026 ($ Millions)

Figure 60. Canada Circulating Tumor Cells Market Size 2021-2026 ($ Millions)

Figure 61. Mexico Circulating Tumor Cells Market Size 2021-2026 ($ Millions)

Figure 62. Brazil Circulating Tumor Cells Market Size 2021-2026 ($ Millions)

Figure 63. China Circulating Tumor Cells Market Size 2021-2026 ($ Millions)

Figure 64. Japan Circulating Tumor Cells Market Size 2021-2026 ($ Millions)

Figure 65. Korea Circulating Tumor Cells Market Size 2021-2026 ($ Millions)

Figure 66. Southeast Asia Circulating Tumor Cells Market Size 2021-2026 ($ Millions)

Figure 67. India Circulating Tumor Cells Market Size 2021-2026 ($ Millions)

Figure 68. Australia Circulating Tumor Cells Market Size 2021-2026 ($ Millions)

Figure 69. Germany Circulating Tumor Cells Market Size 2021-2026 ($ Millions)

Figure 70. France Circulating Tumor Cells Market Size 2021-2026 ($ Millions)

Figure 71. UK Circulating Tumor Cells Market Size 2021-2026 ($ Millions)

Figure 72. Italy Circulating Tumor Cells Market Size 2021-2026 ($ Millions)

Figure 73. Russia Circulating Tumor Cells Market Size 2021-2026 ($ Millions)

Figure 74. Spain Circulating Tumor Cells Market Size 2021-2026 ($ Millions)

Figure 75. Egypt Circulating Tumor Cells Market Size 2021-2026 ($ Millions)

Figure 76. South Africa Circulating Tumor Cells Market Size 2021-2026 ($ Millions)

Figure 77. Israel Circulating Tumor Cells Market Size 2021-2026 ($ Millions)

Figure 78. Turkey Circulating Tumor Cells Market Size 2021-2026 ($ Millions)

Figure 79. GCC Country Circulating Tumor Cells Market Size 2021-2026 ($ Millions)

Please fill the form below, to recieve the report sample


+1